Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
The current Corcept Therapeutics(CORT) stock price is $87.97, with a market capitalization of 9.5B. The stock trades at a price-to-earnings (P/E) ratio of 248.43.
During the trading session on 2026-07-01, Corcept Therapeutics(CORT) shares reached a daily high of $91.00 and a low of $86.04. At a current price of $87.97, the stock is +2.2% higher than the low and still -3.3% under the high.
Trading activity shows a volume of 1.05M, compared to an average daily volume of 1.04M.
Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $91.00 and a low of $28.66.
Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $91.00 and a low of $28.66.
CORT News
Corcept Therapeutics has resubmitted its New Drug Application to the FDA for relacorilant in Cushing’s syndrome, incorporating additional analyses of existing c...
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.